Startseite Publikationen

Publikationen

2016

Ciarlo G, Liebl P, Zell J, Fessler J, Koester MJ, Ruetters D, Mugele K, Huebner J (2016) Information needs of oncologists, general practitioners and other professionals caring for patients with cancer. EUR J Cancer Care, 25: 1015-1023

Ebel MD, Stellamanns J, Keinki C, Rudolph I, Huebner J (2016) Cancer Patients and the Internet: a Survey Among German Cancer Patients. J Cancer Educ

Herth N, Kuenzel U, Liebl P, Keinki C, Zell J, Huebner J (2016) Internet Information for Patients on Cancer Diets - an Analysis of German Websites. Oncol Res Treat, 39: 273-281

Homola M, Pfeffer M, Robson SC, Fischer C, Zimmermann H, Korf HW (2016) Melatonin receptor deficiency decreases and temporally shifts ecto-5'-nucleotidase mRNA levels in mouse prosencephalon. Cell Tissue Res, 365: 147-156

Huebner J, Mohr P, Simon JC, Fluck M, Berking C, Zimmer L, Loquai C (2016) Gebrauch von Komplementärmedizin bei Patienten mit metastasierendem Melanom unter Therapie mit Ipilimumab innerhalb einer klinischen Studie. J Dtsch Dermatol Ges, 14: 508-513

Huebner J, Mohr P, Simon JC, Fluck M, Berking C, Zimmer L, Loquai C (2016) Use of complementary medicine in metastatic melanoma patients treated with ipilimumab within a clinical trial. J Dtsch Dermatol Ges, 14: 508-513

Jung B, Stoll C, Feick G, Prott FJ, Zell J, Rudolph I, Huebner J (2016) Prostate cancer patients' report on communication about endocrine therapy and its association with adherence. J Cancer Res Clin, 142: 465-470

Keinki C, Zowalla R, Wiesner M, Koester MJ, Huebner J (2016) Understandability of Patient Information Booklets for Patients with Cancer. J Cancer Educ

Keinki C, Seilacher E, Ebel M, Ruetters D, Kessler I, Stellamanns J, Rudolph I, Huebner J (2016) Information Needs of Cancer Patients and Perception of Impact of the Disease, of Self-Efficacy, and Locus of Control. J Cancer Educ, 31: 610-616

Kloeppel EM, Hanaya H, Seilacher E, Schroth S, Liebl P, Keinki C, Koester MJ, Huebner J (2016) Utility of a Referral Letter to Improve Comprehensibility of Cancer Patients in Palliative Care: a Single-Center Study. J Cancer Educ

Kohl LJ, von Both U, Huebner J (2016) [Vaccination]. Mmw Fortschr Med, 158: 52-56

Lamb ES, Liebl P, Köster MJ, Hübner J (2016) [An Analysis of contributions to the main German chat forum for cancer patients regarding palliative care]. Deut Med Wochenschr, 141: e106-14

Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, Meiss F, Stein A, Nashan D, Micke O, Muecke R, Muenstedt K, Stoll C, Schmidtmann I, Huebner J (2016) Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma. Med Oncol, 33: 52

Maschke J, Kruk U, Kastrati K, Kleeberg J, Buchholz D, Erickson N, Huebner J (2016) Nutritional care of cancer patients: a survey on patients' needs and medical care in reality. Int J Clin Oncol

Muecke R, Paul M, Conrad C, Stoll C, Muenstedt K, Micke O, Prott FJ, Buentzel J, Huebner J, PRIO (Working Group Prevention and Integrative Oncology of the German Cancer Society) (2016) Complementary and Alternative Medicine in Palliative Care: A Comparison of Data From Surveys Among Patients and Professionals. Integr Cancer Ther, 15: 10-16

Ruetters D, Keinki C, Schroth S, Liebl P, Huebner J (2016) Is there evidence for a better health care for cancer patients after a second opinion? A systematic review. J Cancer Res Clin, 142: 1521-1528

Seidel K, Siswanto S, Fredrich M, Bouzrou M, den Dunnen WFA, Özerden I, Korf HW, Melegh B, de Vries JJ, Brunt ER, Auburger G, Rüb U (2016) On the Distribution of Intranuclear and Cytoplasmic Aggregates in the Brainstem of Patients with Spinocerebellar Ataxia Type 2 and 3. Brain Pathol

Seidel K, Siswanto S, Fredrich M, Bouzrou M, Brunt ER, van Leeuwen FW, Kampinga HH, Korf HW, Rüb U, den Dunnen WFA (2016) Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation. Neuropath Appl Neuro, 42: 153-166

Stratmann K, Heinsen H, Korf HW, Del Turco D, Ghebremedhin E, Seidel K, Bouzrou M, Grinberg LT, Bohl J, Wharton SB, den Dunnen W, Rüb U (2016) Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology. Brain Pathol, 26: 371-386

Wortmann JK, Bremer A, Eich HT, Wortmann HPK, Schuster A, Fühner J, Büntzel J, Muecke R, Prott FJ, Huebner J (2016) Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care. Med Oncol, 33: 78

2015

Czerny C, Eichler K, Croissant Y, Schulz B, Kronreif G, Schmidt R, von Roden M, Schomerus C, Vogl TJ, Marzi I, Zangos S (2015) Combining C-arm CT with a new remote operated positioning and guidance system for guidance of minimally invasive spine interventions. J Neurointerv Surg, 7: 303-308

Ebel MD, Rudolph I, Keinki C, Hoppe A, Muecke R, Micke O, Muenstedt K, Huebner J (2015) Perception of cancer patients of their disease, self-efficacy and locus of control and usage of complementary and alternative medicine. J Cancer Res Clin, 141: 1449-1455

Ebel MD, Stellamanns J, Keinki C, Rudolph I, Huebner J (2015) Cancer Patients and the Internet: a Survey Among German Cancer Patients. J Cancer Educ

Fredrich M, Christ E, Derouiche A, Korf HW (2015) Impact of Melatonin on Zeitgeber Time-Dependent Changes in Cell Proliferation and Apoptosis in the Adult Murine Hypothalamic-Hypophyseal System. Neuroendocrinology, 102: 311-326

Gispert S, Brehm N, Weil J, Seidel K, Rüb U, Kern B, Walter M, Roeper J, Auburger G (2015) Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression. Hum Mol Genet, 15; 24: 1061-1076

Homola M, Pfeffer M, Fischer C, Zimmermann H, Robson SC, Korf HW (2015) Expression of ectonucleotasess in the porsencephalon of melatonin-proficient C3H and melatonin-deficient C56Bl mice: spatial distribution and time-dependent changes. Cell Tissue Res (e-pub)

Hübner J (2015) Several flaws. Deutsch. Ärzteblatt 112: 9

Hübner J, Ebel M, Muenstedt K, Micke O, Prott FJ, Muecke R, Hoppe A (2015) A lecture program on complementary and alternative medicine for cancer patients--evaluation of the pilot phase. J Cancer Educ, 30: 340-343

Hübner J, Prott FJ, Micke O, Münstedt K (2015) Complementary medicine and cancer. Dtsch med. Wochenschrift 140: 768-769

Jung B, Stoll C, Feick G, Prott FJ, Zell J, Rudolph I, Huebner J (2015) Prostate cancer patients' report on communication about endocrine therapy and its association with adherence. J Cancer Res Clin

Keinki C, Seilacher E, Ebel M, Ruetters D, Kessler I, Stellamanns J, Rudolph I, Huebner J (2015) Information Needs of Cancer Patients and Perception of Impact of the Disease, of Self-Efficacy, and Locus of Control. J Cancer Educ

Liebl P, Seilacher E, Koester MJ, Stellamanns J, Zell J, Hübner J (2015) What cancer patients find in the internet: the visibility of evidence-based patient information. Oncol Res Treat 238: 212-218

Linke B, Liebl P, Marten D, Stoll C, Jung B, Wuensch P, Hübner J (2015) Information Concerning Endocrine Therapy and Adherence of Patients with Breast and Prostate Cancer. Clin Oncol-Uk, 27: 482-483

Muecke R, Paul M, Conrad C, Stoll C, Muenstedt K, Micke O, Prott FJ, Buentzel J, Huebner J, PRIO (Working Group Prevention and Integrative Oncology of the German Cancer Society) (2015) Complementary and Alternative Medicine in Palliative Care: A Comparison of Data From Surveys Among Patients and Professionals. Integr Cancer Ther

Müller MH, Rödel F, Rüb U, Korf HW (2015) Irradiation with X-rayse phase-advances the molecular clockwork in liver, adrenal and pancreas. Chronobiol Int 32: 27-36

Pfeffer M, Korf HW, von Gall C (2015) Chronotype and stability of spontaneous locomotor activity rhythm in BMAL1-deficient mice. Chronobiol Int. 32: 81-91

Pfeffer M, Wicht H, von Gall C, Korf HW (2015) Owls and lerks in mice. Frontiers in Neurology http://dx.doi.org/10.3389/fneur.2015.00101

Rüb U, Vonsattel JP, Heinsen H, Korf HW (2015) The neuropathology of Huntington's disease: classical findings, novel developments and correlation to functional neuroanatomy. Adv. Anat Embryol Cell Biol 217: 1-146

Rüb U, Stratmann K, Heinsen H, Del Turco D, Ghebremedhin E, Seidel K, den Dunnen W, Korf HW (2015) Hierarchical Distribution of the Tau Cytoskeletal Pathology in the Thalamus of Alzheimer's Disease Patients. J Alzheimers Dis, 49: 905-915

Rüb U, Korf HW (2015) Consistent and Widespread Degeneration of the Cerebellum in Huntington's Disease (HD). Adv Anat Embryol Cel, 217: 55-66

Rüb U, Seidel K, Vonsattel JP, Lange HW, Eisenmenger W, Götz M, Del Turco D, Boutrou M, Korf HW, Heinsen H (2015) Huntington's disease (HD): neurodegeneration of Brodmann's area 17. Brain Pathol 25: 701-711

Ruetters D, Keinki C, Schroth S, Liebl P, Huebner J (2015) Is there evidence for a better health care for cancer patients after a second opinion? A systematic review. J Cancer Res Clin

Schmid C (2015) Diurnale Veränderungen der Schmerzschwelle am Zahn, ihre Beziehung zum Chronotyp und ihre Relevanz für die zahnärztliche Praxis. Inaugural-Dissertation, Fachbereich Medizin Frankfurt

Schöls L, Reimold M, Seidel K, Globas C, Brockmann K, Karsten Hauser T, Auburger G, Bürk K, den Dunnen W, Reischl G, Korf HW, Brunt ER, Rüb U (2015) No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra. Brain, 138: 3316-3326

Seidel K, Mahlke J, Siswanto S, Krüger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf HW, den Dunnen W, Rüb U (2015) The brainstem pathologies of Parkinson´s disease and dementia with Lewy bodies. Brain Pathol 25: 121-135

Seidel K, Siswanto S, Fredrich M, Bouzrou M, Brunt ER, van Leeuwen FW, Kampinga HH, Korf HW, Rüb U, den Dunnen WFA (2015) Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation. Neuropath Appl Neuro

Stratmann K, Heinsen H, Korf HW, Del Turco D, Ghebremedhin E, Seidel K, Bouzrou M, Grinberg LT, Bohl J, Wharton SB, den Dunnen W, Rüb U (2015) Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology. Brain Pathol

Watcharin W, Schmithals C, Pleli T, Köberle V, Korkusuz H, Hübner F, Waidmann O, Zeuzem S, Korf HW, Terfort A, Gelperina S, Vogl T, Kreuter J, Piiper A (2015) Detection of hepatoceuular carcinoma in transgenic mice by Gd-DPTA-and rhodamine 123-conjugated human serumalbumin nanoparticles in T1 magnetic resonance imaging. J Control Release 199: 63-71

Wuensch P, Hahne A, Haidinger R, Meißler K, Tenter B, Stoll C, Senf B, Huebner J (2015) Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor? J Cancer Res Clin, 141: 55-60

Buchbeiträge

Hübner J (2015) Ernährung bei Tumorpatientenin. In: Schleucher, Barth, Krämer, ritterbusch (Hg.) „Vademecum für die Onkologie“,. Zuckschwerdt Verlag, München

Hübner J (2015) Prävention. In: A. Hegele, L. Skrobek (Hg.) Urologie essentials. Thieme Verlag, Heidelberg

Hübner J (2015) Alternative und komplementäre Medizin in der Tumortherapie. In: Joachim F. Erckenbrecht,Sven Jonas (Hg.) Viszeralmedizin. Springer-Verlag, Heidelberg, 397-460

2014

Conrad AC, Muenstedt K, Micke O, Prott FJ, Muecke R, Huebner J (2014) Attitudes of members of the German Society for Palliative Medicine toward complementary and alternative medicine for cancer patients. J Cancer Res Clin Oncol 140: 1229-1237

Hübner J, Prott FJ, Micke O, Muecke R, Senf B, Dennert G, Muenstedt K (2014) Online survey of cancer patients on complementary and alternative medicine. Oncol ResTreat 37: 304-308

Hübner J, Muenstedt K, Prott FJ, Stoll C, Micke O, Buentzel J, Muecke R, Senf B (2014) Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care (Basel) 9: 60-63

Hübner J, Muecke R (2014) Arginine-supplemented enteral nutrition. J Cancer Res Clin Oncol 140: 681-683

Hübner J, Micke O, Muecke R, Buentzel J, Prott FJ, Kleeberg U, Senf B, Muenstedt K; PRIO (Working Group Prevention and Integrative Oncology of the German Cancer Society) (2014) User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer Res 34(2)

Hübner J, Marienfeld S, Abbenhardt C, Ulrich C, Muenstedt K, Micke O, Muecke R, Loeser C (2014) Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice. Anticancer Res 34: 39-48

Hübner J, Rosé C, Geissler J, Gleiter CH, Prott FJ, Muenstedt K, Micke O, Muecke R, Buentzel J, Bottomley A, Hofheinz RD (2014) Integrating cancer patients' perspectives into treatment decisions and treatment evaluation using patient-reported outcomes--a concept paper. Eur J Cancer Care (Engl). 23: 173-179

Koehl B, Muenstedt K, Micke O, Muecke R, Buentzel J, Stoll C, Prott FJ, Dennert G, Senf B, Huebner J (2014) Survey of German non-medical practitioners regarding complementary and alternative medicine in oncology. Oncol Res Treat. 37: 49-53

Muecke R, Micke O, Schomburg L, Buentzel J, Adamietz IA, Huebner J (2014) Serum Selenium Deficiency in Patients with Hematological Malignancies: Is a Supplementation Study Mandatory? Acta Haematol 132: 256-258

Noichl E (2014) Charakterisierung der HSF1-Immunreaktion im Hypothalamus der C3H Maus. Inaugural-Dissertation, Fachbereich Medizin Frankfurt

Rüb U, Hentschel M, Stratmann K, Brunt E, Heinsen H, Seidel K, Bouzrou M, Auburger G, Paulson H, Vonsattel JP, Lange H, Korf HW, den Dunnen W (2014) Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem. Brain Pathol 24: 247-260

Seidel K, Küsters B, den Dunnen WF, Bouzrou M, Hageman G, Korf HW, Schelhaas HJ, Verbeek D, Rüb U (2014) First patho-anatomical investigation of the brain of a SCA19 patient. Neuropathol Appl Neurobiol 40: 640-644

Watcharin W, Schmithals C, Pleli T, Köberle V, Korkusuz H, Hübner F, Zeuzem S, Korf HW, Vogl T, Rittmeyer C, Terfort A, Piiper A, Gelperina S, Kreuter J. Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging. Eur J Pharm Biophatm 87: 132-141

Wicht H, Korf HW, Ackermann H, Ekhart D, Fischer C, Pfeffer M (2014) Chronotypes and rhythm stability in mice. Chronobiol Int 31:27-36.

Yasuo S, Fischer C, Bojunga J, Iigo M, Korf HW (2014) 2-Arachidonoyl glycerol sensitizes the pars distalis and enhances forskolin-stimulated prolactin secretion in Syrian hamsters. Chronobiol Int 31: 337-342

2013

Conrad C, Muenstedt K, Micke O, Prott F, Gronau T, Muecke R, Stoll C, Buentzel J, Huebner J (2013) Survey of members of the German Society for Palliative Medicine regarding their attitudes toward complementary and alternative medicine for cancer patients. J Palliat Med, 16: 822-824

Dennert G, Hübner J, Micke O, Mücke R, Muenstedt K, Prott FJ, Senf B, Stoll C (2013) Komplementäre und alternative Medizin – Empfehlungen zu den vorhandenen Patienteninformationen im Internet. Forum 28: 52-53

Elsner T, Muecke R, Micke O, Prott FJ, Muenstedt K, Waldmann A, Geissler J, Huebner J (2013) Survey on the worldwide Chronic Myeloid Leukemia Advocates Network regarding complementary and alternative medicine. J Cancer Res Clin Oncol, 139: 1025-1031

Fredrich M, Zeber AC, Hildebrandt H, Illing RB (2013) Differential molecular profiles of astrocytes in degeneration and re-innervation after sensory deafferentation of the adult rat cochlear nucleus. Eur J Neurosci, 38: 2041-2056

Goto M, Matsuo H, Iigo M, Furuse M, Korf HW, Yasuo S (2013) Melatonin-induced changes in the expression of thyroid hormone-converting enzymes in hypothalamus depend on the timing of melatonin injections and genetic background in mice. Gen Comp Endocrinol, 186C: 33-40

Haseleu J, Anlauf E, Blaess S, Endl E, Derouiche A (2013) Studying subcellular detail in fixed astrocytes: dissociation of morphologically intact glial cells (DIMIGs). Cell Neurosci [Epub ahead of print]

Huber R, Hübner J, Wolf U (2013) Phytotherapie in der Onkologie. Onkologe 19: 132-135

Hübner J, Follmann M (2013) Complementary medicine in guidelines of the German Guideline Program in Oncology: comparison of the evidence base between complementary and conventional therapy. J Cancer Res Clin Oncol, 139: 1481-1488

Hübner J, Micke O, Muecke R, Prott FJ, Stoll C, Muenstedt K (2013) Comparison of reviews in complementary and alternative medicine (CAM) in oncology: do results depend on methodology? Trace Elements and Electrolytes, DOI 10.5414/TEX01299: DOI 10.5414/TEX01299

Hübner J, Muenstedt K, Muecke R, Micke O (2013) The integration of methods from complementary and alternative medicine in reviews on supportive therapy in oncology and the resulting evidence. Trace Elements and Electrolytes, 30/1: 24-28

Hübner J, Muenstedt K, Muecke R, Micke O, Stoll C, Kleeberg UR, Buentzel J, Dennert G, Prott FJ (2013) Counseling cancer patients on complementary and alternative medicine. Strahlentherapie und Onkologie, 189: 613-617

Hübner J, Muenstedt K, Muecke R, Micke O (2013) Is there level I evidence for complementary and alternative medicine (CAM) in oncology? An analysis of Cochrane Reviews. Trace Elements and Electrolytes, 30/1: 29-34

Hübner J, Muenstedt K, Senf B, Micke O (2013) Analysis of the Contents of German Magazines for Tumor Patients. Forsch Komplementmed. Forsch Komplementmed, 20: 120-128

Hübner J, Rosé C, Geissler J, Gleiter CH, Prott FJ, Muenstedt K, Micke O, Muecke R, Buentzel J, Bottomley A, Hofheinz RD (2013) Integrating cancer patients' perspectives into treatment decisions and treatment evaluation using patient-reported outcomes - a concept paper. Eur J Cancer Care

Hübner J, Hanf V (2013) Commonly Used Methods of Complementary Medicine in the Treatment of Breast Cancer. Breast Care (Basel), 8: 341-347

Hübner J, Senf B, Micke O, Muecke R, Stoll C, Prott FJ, Muenstedt K, Dennert G, working group Prevention and Integrative Oncology (PRIO) of the German Cancer Society (2013) Online information on complementary and alternative medicine for cancer patients: evidence-based recommendations. Onkologie, 36: 273-278

Hübner J (2013) Krebsdiäten – ein Mythos? Forum onkologische Pflege, Forum onkologische Pflege 2: 24-26

Hübner J (2013) Komplementäre Onkologie. Onkologe, Onkologe 19: 970-977

Hübner J (2013) Was ist komplementäre Medizin? Geburtsh Frauenheilk 73: 104-106

Hübner J (2013) Komplementäre und Alternative Medizin in der Onkologie (Teil I). Versicherungsmedizin, Versicherungsmedizin 65: 79-83

Hübner J, Loeser C, Stoll C (2013) Welche Vorstellungen von Genese und Therapie von Malignomen liegen den in Deutschland angebotenen Krebsdiäten zugrunde – eine kritische Analyse mit Empfehlungen für die ärztliche Beratung. Onkologe 2013; doi 10.1007/s: 00761-012-2381-0

Hübner J, Muenstedt K (2013) Beratung von Patientinnen mit gynäkologischen Tumoren zur Komplementären und Alternativen Medizin (KAM): Gibt es einen Königsweg? Geburtsh Frauenheilk 73: 35-39

Hübner J, Muenstedt K, Micke O, Senf B (2013) Informationen zur komplementären und alternativen Medizin auf den Internetseiten deutscher Selbsthilfegruppen für Tumorpatienten. DMW, 138: 17-22

Hübner J, Muenstedt K, Stoll C, van Oorschot B, Lordick F (2013) Komplementäre und alternative Medizin in der Palliativmedizin bei Tumorpatienten. Onkologe 19:101-107

Hübner J, Schulte-Bosse B (2013) Der „Nikolausbeschluss“ und das GKV-Versorgungsstrukturgesetz. Onkologe, Onkologe 19: 402-407

Micke O, Schomburg L, Kisters K, Buentzel J, Huebner J, Muecke R (2013) Selenium and hypertension: do we need to reconsider selenium supplementation in cancer patients? J Hypertens, 31: 1049-1050

Muecke R, Micke O, Schomburg L, Buentzel J, Glatzel M, Baaske D, Berndt-Skorka R, Prott FJ, Reichl B, Kisters K, Schaefer U, Hübner J, Eich HT, Kundt G, Adamietz IA (2013) Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial. Radiat Oncol, 8: 72

Münstedt K, Dütemeyer V, Hübner J (2013) Patients' considerations behind the use of methods from complementary and alternative medicine in the field of obstetrics in Germany. Arch Gynecol Obstet, 288: 527-530

Münstedt K, Hübner J (2013) Alternative Medizin bei Tumorerkrankungen. Onkologe 19: 117-124

Paul M, Davey B, Senf B, Stoll C, Muenstedt K, Muecke R, Micke O, Prott FJ, Buentzel J, Hübner J (2013) Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Research and Clinical Oncology, 130: 1515-1522

Rüb U, Schöls L, Paulson H, Auburger G, Kermer P, Jen JC, Seidel K, Korf HW, Deller T (2013) Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol, 104: 38-66

Rüb U, Farrag K, Seidel K, Brunt E, Heinsen H, Bürk K, Melegh B, von Gall C, Auburger G, Bohl J, Korf HW, Hoche F, den Dunnen W (2013) Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2). Neuropath Appl Neuro, 39: 634-643

Rüb U, Hoche F, Brunt E, Heinsen H, Seidel K, Del Turco D, Paulson H, Bohl J, von Gall C, Vonsattel J, Korf HW, den Dunnen W (2013) Degeneration of the cerebellum in Huntington's disease (HD): Possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. Brain Pathol, 23: 165-177

Trimborn A, Senf B, Muenstedt K, Buentzel J, Micke O, Muecke R, Prott FJ, Wicker S, Hübner J, Working Group Prevention and Integrative Oncology of the German Cancer Society (2013) Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol, 24: 2641-2645

Yasuo S, Fischer C, Bojunga J, Iigo M, Korf HW (2013) 2-Arachidonoyl glycerol sensitizes the pars distalis and enhances forskolin-stimulated prolactin secretion in Syrian hamsters. Chronobiol Int

2012

Christ E, Korf HW, von Gall C (2012) When does it start ticking? Ontogenetic development of the mammalian circadian system. Prog Brain Res, 199: 105-118

Ekhart D, Hübner J, Wicker S, Nierhoff J, Ackermann H, Herrmann E, Korf HW (2012) Comparison between the chronotype of breast cancer patients and healthy probands. Abstract, Leopoldina-Symposium “The circadian system: from chronobiology to chronomedicine”, S. 30

Fischer C, Christ E, Korf HW, von Gall C (2012) Tafa-3 encoding for a secretory peptide is expressed in the mouse pars tuberalis and is affected by melatonin 1 receptor deficiency. Gen Comp Endocrinol (e-pub)

Korf HW, von Gall C (2012) Circadian physiology. In: Neuroscience in the 21 century (D.W. Pfaff, ed) Springer

Müller M, Durante M, Natale F, Stöcker H, Korf HW (2012) Are 12C radiation effects in liver tissue time-dependent? Abstract, Leopoldina-Symposium “The circadian system: from chronobiology to chronomedicine”, S. 25

Nierhoff J, Ekhart D, Schmidt A, Korf HW, Hübner J, Wicker S, Herrmann E, Ackermann H (2012) Biostatistical methods pf a chronotype trial. Abstract, Leopoldina-Symposium “The circadian system: from chronobiology to chronomedicine”, S. 28

Pfeffer M, Plenzig S, Gispert S, Wada K, Korf HW, Von Gall C (2012a) Disturbed sleep/wake rhythms and neuronal cell loss in lateral hypothalamus and retina of mice with a spontaneous deletion in the ubiquitin carboxyl-terminal hydrolase L1 gene. Neurobiol Aging 33: 393-403

Pfeffer M, Rauch A, Korf HW, von Gall C (2012b) The Endogenous Melatonin (MT) Signal Facilitates Reentrainment of the Circadian System to Light-Induced Phase Advances by Acting Upon MT2 Receptors. Chronobiology Int 29: 415-429 (e-pub)

Rüb U, Bürk K, Timmann D, den Dunnen W, Seidel K, Brunt E, Heinsen H, Egensperger R, Bornemann A, Schwarzacher S, Korf HW, Schöls L, Bohl J, Deller T (2012) Spinocerebellar ataxia type 1 (SCA1): New pathoanatomical and clinico-pathological insights. Neuropathol Appl Neurobiol (e-pub)

Scherzed W, Brunt ER, Heinsen H, de Vos RA, Seidel K, Bürk K, Schöls L, Auburger G, Del Turco D, Deller T, Korf HW, den Dunnen WF, Rüb U (2012) Pathoanatomy of Cerebellar Degeneration in Spinocerebellar Ataxia Type 2 (SCA2) and Type 3 (SCA3). Cerebellum 11: 749-760 (e-pub)

Schmidt A, Ekhart D, Wicker S, Nierhoff J, Ackermann H, Herrmann E, Hübner J, Korf HW (2012) Correlation between chronotype (MSFsc) and lifestyle-factors. Abstract, Leopoldina-Symposium “The circadian system: from chronobiology to chronomedicine”, S. 29

Seidel K, Meister M, Dugbartey GJ, Zijlstra MP, Vinet J, Brunt ER, van Leeuwen FW, Rüb U, Kampinga HH, den Dunnen WF (2012) Cellular protein quality control and the evolution of aggregates in SCA3. Neuropathol Appl Neurobiol 124: 1-21 (e-pub)

Seidel K, Vinet J, Dunnen WF, Brunt ER, Meister M, Boncoraglio A, Zijlstra MP, Boddeke HW, Rüb U, Kampinga HH, Carra S (2012) The HSPB8-BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases. Neuropathol Appl Neurobiol 38: 39-53

Yasuo S, Unfried C, Bojunga J, Iigo M, Otsuka T, Togo Y, Schreiber Y, Geisslinger G, Korf HW (2012) Sensitizing effects of  2-arachodonoylglycerol on hypophysis and hypothalamus of mammals. Abstract, Leopoldina-Symposium “The circadian system: from chronobiology to chronomedicine”, S. 16

2011

Lavialle M, Aumann G, Anlauf E, Pröls F, Arpin M, Derouiche A (2011) Structural plasticity of perisynaptic astrocyte processes involves ezrin and metabotropic glutamate receptors. Proc Natl Acad Sci 108:12915-12919

Yasuo S, Korf HW (2011) The hypophysial pars tuberalis transduces photoperiodic signals via multiple pathways and messenger molecules. Gen Comp Endocrinol 172: 15-22

2010

Hoche F, Balikó L, den Dunnen W, Steinecker K, Bartos L, Sáfrány E, Auburger G, Deller T, Korf HW, Klockgether T, Rüb U, Melegh B (2010) Spinocerebellar Ataxia Type 2 (SCA2): Identification of Early Brain Degeneration in One Monozygous Twin in the Initial Disease Stage. Cerebellum 10: 245-253

Merz F, Müller M, Taucher-Scholz G, Rödel F, Stöcker H, Schopow K, Laprell L, Dehghani F, Durante M, Bechmann I (2010) Tissue slice cultures from humans or rodents: a new tool to evaluate biological effects of heavy ions. Radiat Environ Biophys 49: 457-462

Unfried C, Burbach G, Korf HW, von Gall C (2010) Melatonin receptor 1-dependent gene expression in the mouse pars tuberalis as revealed by cDNA microarray analysis and in situ hybridization. J Pineal Res 48: 148-156

Yasuo S, Koch M, Schmidt H, Ziebell S, Bojunga J, Geisslinger G, Korf HW (2010a) An endocannabinoid system is localized to the hypophysial pars tuberalis of Syrian hamsters and responds to photoperiodic changes. Cell Tissue Res 340: 127-136

Yasuo S, Unfried C, Kettner M, Geisslinger G, Korf HW (2010b) Localization of an endocannabinoid system in the hypophysial pars tuberalis and pars distalis of man. Cell Tissue Res 342: 273-281